Why a buyout offer is iminent. We have a 38mm market cap. We have 60mm vaccine plant. We have a FDA trial complete blockbuster in MCNA. 400mm to 1.5b revenue. We have an 80mm?? tax loss which huge for any buyer with revenue. We have an MCNA manufacturing facility in Montreal. We have a head office in Belleville likely worth 5 to 6mm. We have Econiche (yes don't roll on the floor laughing- grits might still come into power and pull a rabbit out of the hat) We have Sin Susto human and its enormous market size. We have oncocidin adjuvant with its multi billion market potential. We have 10mm in cash. Brace yourselves....it coming.